148 related articles for article (PubMed ID: 35003082)
1. Vulnerability to Meningococcal Disease in Immunodeficiency Due to a Novel Pathogenic Missense Variant in
Anim M; Sogkas G; Schmidt G; Dubrowinskaja N; Witte T; Schmidt RE; Atschekzei F
Front Immunol; 2021; 12():767188. PubMed ID: 35003082
[TBL] [Abstract][Full Text] [Related]
2. A Pathogenic Missense Variant in
Fliegauf M; Krüger R; Steiner S; Hanitsch LG; Büchel S; Wahn V; von Bernuth H; Grimbacher B
Front Immunol; 2021; 12():621503. PubMed ID: 33995346
[TBL] [Abstract][Full Text] [Related]
3. Detrimental
Fliegauf M; Kinnunen M; Posadas-Cantera S; Camacho-Ordonez N; Abolhassani H; Alsina L; Atschekzei F; Bogaert DJ; Burns SO; Church JA; Dückers G; Freeman AF; Hammarström L; Hanitsch LG; Kerre T; Kobbe R; Sharapova SO; Siepermann K; Speckmann C; Steiner S; Verma N; Walter JE; Westermann-Clark E; Goldacker S; Warnatz K; Varjosalo M; Grimbacher B
Front Immunol; 2022; 13():965326. PubMed ID: 36105815
[TBL] [Abstract][Full Text] [Related]
4. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans.
Tuijnenburg P; Lango Allen H; Burns SO; Greene D; Jansen MH; Staples E; Stephens J; Carss KJ; Biasci D; Baxendale H; Thomas M; Chandra A; Kiani-Alikhan S; Longhurst HJ; Seneviratne SL; Oksenhendler E; Simeoni I; de Bree GJ; Tool ATJ; van Leeuwen EMM; Ebberink EHTM; Meijer AB; Tuna S; Whitehorn D; Brown M; Turro E; Thrasher AJ; Smith KGC; Thaventhiran JE; Kuijpers TW;
J Allergy Clin Immunol; 2018 Oct; 142(4):1285-1296. PubMed ID: 29477724
[TBL] [Abstract][Full Text] [Related]
5. Late-Onset Antibody Deficiency Due to Monoallelic Alterations in
Schröder C; Sogkas G; Fliegauf M; Dörk T; Liu D; Hanitsch LG; Steiner S; Scheibenbogen C; Jacobs R; Grimbacher B; Schmidt RE; Atschekzei F
Front Immunol; 2019; 10():2618. PubMed ID: 31803180
[TBL] [Abstract][Full Text] [Related]
6. Haploinsufficiency of the NF-κB1 Subunit p50 in Common Variable Immunodeficiency.
Fliegauf M; Bryant VL; Frede N; Slade C; Woon ST; Lehnert K; Winzer S; Bulashevska A; Scerri T; Leung E; Jordan A; Keller B; de Vries E; Cao H; Yang F; Schäffer AA; Warnatz K; Browett P; Douglass J; Ameratunga RV; van der Meer JW; Grimbacher B
Am J Hum Genet; 2015 Sep; 97(3):389-403. PubMed ID: 26279205
[TBL] [Abstract][Full Text] [Related]
7. Biochemically deleterious human NFKB1 variants underlie an autosomal dominant form of common variable immunodeficiency.
Li J; Lei WT; Zhang P; Rapaport F; Seeleuthner Y; Lyu B; Asano T; Rosain J; Hammadi B; Zhang Y; Pelham SJ; Spaan AN; Migaud M; Hum D; Bigio B; Chrabieh M; Béziat V; Bustamante J; Zhang SY; Jouanguy E; Boisson-Dupuis S; El Baghdadi J; Aimanianda V; Thoma K; Fliegauf M; Grimbacher B; Korganow AS; Saunders C; Rao VK; Uzel G; Freeman AF; Holland SM; Su HC; Cunningham-Rundles C; Fieschi C; Abel L; Puel A; Cobat A; Casanova JL; Zhang Q; Boisson B
J Exp Med; 2021 Nov; 218(11):. PubMed ID: 34473196
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the clinical and immunologic phenotype and management of 157 individuals with 56 distinct heterozygous NFKB1 mutations.
Lorenzini T; Fliegauf M; Klammer N; Frede N; Proietti M; Bulashevska A; Camacho-Ordonez N; Varjosalo M; Kinnunen M; de Vries E; van der Meer JWM; Ameratunga R; Roifman CM; Schejter YD; Kobbe R; Hautala T; Atschekzei F; Schmidt RE; Schröder C; Stepensky P; Shadur B; Pedroza LA; van der Flier M; Martínez-Gallo M; Gonzalez-Granado LI; Allende LM; Shcherbina A; Kuzmenko N; Zakharova V; Neves JF; Svec P; Fischer U; Ip W; Bartsch O; Barış S; Klein C; Geha R; Chou J; Alosaimi M; Weintraub L; Boztug K; Hirschmugl T; Dos Santos Vilela MM; Holzinger D; Seidl M; Lougaris V; Plebani A; Alsina L; Piquer-Gibert M; Deyà-Martínez A; Slade CA; Aghamohammadi A; Abolhassani H; Hammarström L; Kuismin O; Helminen M; Allen HL; Thaventhiran JE; Freeman AF; Cook M; Bakhtiar S; Christiansen M; Cunningham-Rundles C; Patel NC; Rae W; Niehues T; Brauer N; Syrjänen J; Seppänen MRJ; Burns SO; Tuijnenburg P; Kuijpers TW; ; Warnatz K; Grimbacher B;
J Allergy Clin Immunol; 2020 Oct; 146(4):901-911. PubMed ID: 32278790
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae.
Tuovinen EA; Kuismin O; Soikkonen L; Martelius T; Kaustio M; Hämäläinen S; Viskari H; Syrjänen J; Wartiovaara-Kautto U; Eklund KK; Saarela J; Varjosalo M; Kere J; Hautala T; Seppänen MRJ
Clin Immunol; 2023 Jan; 246():109181. PubMed ID: 36356849
[TBL] [Abstract][Full Text] [Related]
10. Case Report: A child with NFKB1 haploinsufficiency explaining the linkage between immunodeficiency and short stature.
Ricci S; Abu-Rumeileh S; Campagna N; Barbati F; Stagi S; Canessa C; Lodi L; Palterer B; Maggi L; Matucci A; Vultaggio A; Annunziato F; Azzari C
Front Immunol; 2023; 14():1224603. PubMed ID: 37600787
[TBL] [Abstract][Full Text] [Related]
11. Resolving the polygenic aetiology of a late onset combined immune deficiency caused by NFKB1 haploinsufficiency and modified by PIK3R1 and TNFRSF13B variants.
Hargreaves CE; Dhalla F; Patel AM; de Oteyza ACG; Bateman E; Miller J; Anzilotti C; Ayers L; Grimbacher B; Patel SY
Clin Immunol; 2022 Jan; 234():108910. PubMed ID: 34922003
[TBL] [Abstract][Full Text] [Related]
12. Common variable immunodeficiency in two kindreds with heterogeneous phenotypes caused by novel heterozygous
Staels F; De Keukeleere K; Kinnunen M; Keskitalo S; Lorenzetti F; Vanmeert M; Prezzemolo T; Pasciuto E; Lescrinier E; Bossuyt X; Gerbaux M; Willemsen M; Neumann J; Van Loo S; Corveleyn A; Willekens K; Stalmans I; Meyts I; Liston A; Humblet-Baron S; Seppänen M; Varjosalo M; Schrijvers R
Front Immunol; 2022; 13():973543. PubMed ID: 36203612
[TBL] [Abstract][Full Text] [Related]
13. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes.
Kaustio M; Haapaniemi E; Göös H; Hautala T; Park G; Syrjänen J; Einarsdottir E; Sahu B; Kilpinen S; Rounioja S; Fogarty CL; Glumoff V; Kulmala P; Katayama S; Tamene F; Trotta L; Morgunova E; Krjutškov K; Nurmi K; Eklund K; Lagerstedt A; Helminen M; Martelius T; Mustjoki S; Taipale J; Saarela J; Kere J; Varjosalo M; Seppänen M
J Allergy Clin Immunol; 2017 Sep; 140(3):782-796. PubMed ID: 28115215
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel NFKB1 and ICOS frameshift variants in patients with CVID.
Liu A; Liu Q; Leng S; Zhang X; Feng Q; Peng J; Feng G
Clin Exp Immunol; 2023 Mar; 211(1):68-77. PubMed ID: 36571238
[TBL] [Abstract][Full Text] [Related]
15. Corrigendum: Vulnerability to meningococcal disease in immunodeficiency due to a novel pathogenic missense variant in
Anim M; Sogkas G; Schmidt G; Dubrowinskaja N; Witte T; Schmidt RE; Atschekzei F
Front Immunol; 2023; 14():1212029. PubMed ID: 37234149
[TBL] [Abstract][Full Text] [Related]
16. Combined immunodeficiency caused by a novel homozygous NFKB1 mutation.
Mandola AB; Sharfe N; Nagdi Z; Dadi H; Vong L; Merico D; Ngan B; Reid B; Roifman CM
J Allergy Clin Immunol; 2021 Feb; 147(2):727-733.e2. PubMed ID: 32980423
[TBL] [Abstract][Full Text] [Related]
17. Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disorders.
Ameratunga R; Ahn Y; Jordan A; Lehnert K; Brothers S; Woon ST
Expert Rev Clin Immunol; 2018 Jul; 14(7):549-556. PubMed ID: 29806948
[TBL] [Abstract][Full Text] [Related]
18. A large deletion in a non-coding regulatory region leads to NFKB1 haploinsufficiency in two adult siblings.
Fusaro M; Coustal C; Barnabei L; Riller Q; Heller M; Ho Nhat D; Fourrage C; Rivière S; Rieux-Laucat F; Maria ATJ; Picard C
Clin Immunol; 2024 Apr; 261():110165. PubMed ID: 38423196
[TBL] [Abstract][Full Text] [Related]
19. Acquired and Innate Immunity Impairment and Severe Disseminated
Gonzalez-Granado LI; Ruiz-García R; Blas-Espada J; Moreno-Villares JM; Germán-Diaz M; López-Nevado M; Paz-Artal E; Toldos O; Rodriguez-Gil Y; de Inocencio J; Domínguez-Pinilla N; Allende LM
Front Immunol; 2018; 9():3148. PubMed ID: 30761159
[No Abstract] [Full Text] [Related]
20. Th1-skewed profile and excessive production of proinflammatory cytokines in a NFKB1-deficient patient with CVID and severe gastrointestinal manifestations.
Dieli-Crimi R; Martínez-Gallo M; Franco-Jarava C; Antolin M; Blasco L; Paramonov I; Semidey ME; Álvarez Fernández A; Molero X; Velásquez J; Martín-Nalda A; Pujol-Borrell R; Colobran R
Clin Immunol; 2018 Oct; 195():49-58. PubMed ID: 30063981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
